ARQT
Arcutis Biotherapeutics, Inc. Healthcare - Biotechnology Investor Relations →
Arcutis Biotherapeutics, Inc. (ARQT) closed at $27.32 as of 2026-02-02, trading 95.7% above its 200-week moving average of $13.96. The stock moved further from the line this week, up from 82.2% last week. The 14-week RSI sits at 55, indicating neutral momentum.
Over the past 266 weeks of data, ARQT has crossed below its 200-week moving average 6 times. On average, these episodes lasted 34 weeks. The average one-year return after crossing below was -39.8%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $3.3 billion, ARQT is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -28.2%. The stock trades at 20.8x book value.
Share count has increased 134.5% over three years, indicating dilution.
Over the past 5.2 years, a hypothetical investment of $100 in ARQT would have grown to $100, compared to $200 for the S&P 500. ARQT has returned 0.0% annualized vs 14.3% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Growth of $100: ARQT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ARQT Crosses Below the Line?
Across 6 historical episodes, buying ARQT when it crossed below its 200-week moving average produced an average return of -41.0% after 12 months (median -40.0%), compared to +5.3% for the S&P 500 over the same periods. After 24 months, the average return was -61.0% vs +17.3% for the index.
Each line shows $100 invested at the moment ARQT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ARQT has crossed below its 200-week MA 6 times with an average 1-year return of +-39.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2021 | Apr 2021 | 2 | 3.3% | -20.7% | +2.6% |
| May 2021 | Aug 2022 | 64 | 42.7% | -30.4% | +6.1% |
| Aug 2022 | Mar 2025 | 132 | 90.8% | -68.4% | +11.7% |
| Apr 2025 | Apr 2025 | 2 | 10.4% | N/A | +117.0% |
| May 2025 | May 2025 | 1 | 1.9% | N/A | +101.9% |
| May 2025 | Jun 2025 | 3 | 4.4% | N/A | +109.5% |
| Average | 34 | — | +-39.8% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02